Antiplatelet drug

(redirected from Antiplatelet medication)
Also found in: Wikipedia.

Antiplatelet drug

Drug that inhibits platelets from aggregating to form a plug. They are used to prevent clotting and alter the natural course of atherosclerosis.
References in periodicals archive ?
Since the goal of this study was to assess association of oral anticoagulant or antiplatelet medication in BCG treated patients with prognosis, all papers not reporting any outcome correlations were excluded.
The VerifyNow P2Y12 Test offers a simple and rapid means of assessing an individual's response to antiplatelet medication.
RESULTS: Independent of antiplatelet medication, an interquartile range (IQR) increase of 39.
With the thrombin receptor antagonist, TRA or SCH-530348, our novel investigational antiplatelet medication in late-stage development; the Merck/Schering-Plough cholesterol-lowering products VYTORIN and ZETIA; and INTEGRILIN, the leading GP IIb-IIIa inhibitor, acadesine further demonstrates our long-term commitment to developing treatments to address unmet needs in cardiac care.
During the course of his stay in the hospital, the patient received Plavix, an antiplatelet medication.
The conclusion was drawn that preoperative antiplatelet medication was not a contraindication for regional anesthesia.
SAN DIEGO, May 8, 2015 /PRNewswire/ -- A risk assessment algorithm combining clinical risk factors and platelet function test results may help interventional cardiologists better identify patients who stand to benefit from intensive antiplatelet medication after percutaneous coronary intervention (PCI), according to results of the TRIAGE study presented today as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2015 Scientific Sessions in San Diego.
Patients were considered to be high risk for a GI bleed if they were aged 65 years or older, had a history of upper GI disease, a co-prescription with an anticoagulant or antiplatelet medication, a previous bleed, and other comorbid conditions like rheumatoid arthritis.
Molenaar added that no concomitant treatment occurred with antiplatelet medication.
In case 1, coronary intervention and antiplatelet medication without glycoprotein IIb-IIIa inhibitors was not sufficient to treat severe coronary plaque instability and platelet hyperreactivity, as indicated by excessive and persistent whole-blood hypercholinemia (>100 [micro]mol/L), and the patient died of sudden cardiac death shortly after hospital discharge.
The group who took antiplatelet medication had a 15% reduction in the risk of preeclampsia, compared with those who took a placebo or no agent.
The study examined prescribing patterns for patients with recent acute coronary syndrome (ACS) or percutaneous coronary intervention (PCI) who were prescribed the antiplatelet medication clopidogrel.